Drug intelligence / Profile preview

AdSmCB

Development stage
Preclinical
Lead developer
Research Institute of the McGill University Health Centre
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

AdSmCB is a recombinant human adenovirus serotype 5 (HAdV-5) viral vector vaccine expressing *Schistosoma mansoni* cathepsin B (SmCB), a parasitic gut peptidase essential for helminth growth and maturation. Developed by researchers at the Research Institute of the McGill University Health Centre and the National Research Council Canada, AdSmCB is designed as a prophylactic vaccine for intestinal schistosomiasis. In preclinical models, intramuscular administration of AdSmCB followed by recombinant protein boosts (such as SmCB adjuvanted with AddaVax) elicits robust humoral and cell-mediated immune responses, including antigen-specific IgG1, IgG2c, serum IgA, and Th1/Th2 cytokines, leading to a significant reduction in parasite burden and associated liver pathology.

Other names
AdV-SmCBrecombinant adenovirus expressing Schistosoma mansoni cathepsin B

Beyond the preview

Go deeper on AdSmCB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AdSmCB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call